Tag: cancer
Is ‘junk DNA’ a key to killing cancer cells?
Rochester biologists show how a selfish genetic element called retrotransposons that can cause tumors may also trigger the death of cancer cells.
Listening to family stories helps cancer researchers identify gaps in care
A Wilmot Cancer Institute study of more than 90 families and caregivers looked for common threads about their loved one’s final transition from active treatment to death and dying.
Cancer ‘fight’ may keep men from palliative care
According to a University of Rochester Medical Center study, men with advanced cancer are 30 percent less likely than women to consider palliative care, and may view palliative options as a sign of “giving up.”
Simple post-surgery step reduces bladder cancer recurrence
Flushing the bladder with a common chemotherapy drug immediately after surgery significantly reduces the chances of bladder cancer returning, according to a major study led by the Medical Center.
Why do naked mole rats live long, cancer-free lives?
Rochester biologists were surprised to see that despite its remarkable longevity, the naked mole rat still has cells that undergo senescence, like the cells in much shorter-lived mice.
Research is changing the game for melanoma treatment
Some Wilmot Cancer Institute patients with advanced melanoma may have longer disease-free survival thanks to new drug treatment options tested by Rochester researchers.
Pancreatic tumors may require a one-two-three punch
Wilmot Cancer Institute scientists have discovered that a three-drug combination can simultaneously target the cancer cells as well as the other harmful, inflammatory cells within the tumor.
Newest data links inflammation to chemo-brain
Chemo-brain, or cancer-related cognitive impairment, is estimated to impact 80 percent of people in treatment. A new Medical Center study shows that inflammation in the blood plays a key role.
Rochester chemists find new means to ‘block’ cancer cell growth
A pathway that enables embryonic cells to develop into different organs can be reactivated by cancer cells. A cyclic peptide has been found that can block the activation of this pathway, and is also less likely to trigger resistance in cancer cells.
‘Microbubbles’ boost search for head, neck cancer treatment
A Medical Center team recently received a $3.8 million grant to continue their investigation of an innovative technology that could lead to preventative treatments for radiation damage in patients.